News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Stephen V Liu: Alexander Drilon at CIOT25 Clearly Favoring Taletrectinib as 1L for ROS1 NSCLC
Stephen V Liu and Alexander Drilon
Jun 20, 2025, 09:34

Stephen V Liu: Alexander Drilon at CIOT25 Clearly Favoring Taletrectinib as 1L for ROS1 NSCLC

Stephen V Liu, Director of Thoracic Oncology and Associate Professor of Medicine at Georgetown University, shared a post on X:

“Dr. Alexander Drilon at CIOT25 clearly favoring taletrectinib as 1L for ROS1 NSCLC – potential and better tox profile. NVL-520 zidesamtinib poised to potentially be best in class. For RET, after selpercatinib or pralsetinib, few options. EP0031 is one in development.”

CIOT25

More posts featuring Stephen V Liu.

 

Alexander Drilon cancer CIOT25 NSCLC OncoDaily Oncology ROS1+ NSCLC Stephen V Liu Taletrectinib
Special Coverage
Blog
Jun 20, 2025, 09:34
Stephen V Liu: Alexander Drilon at CIOT25 Clearly Favoring Taletrectinib as 1L for ROS1 NSCLC
Blog
Jun 20, 2025, 09:23
Aakash Desai Shared PLAN Study on Plasma-First NGS in Advanced NSCLC
Blog
Jun 20, 2025, 09:22
Jasmine Kamboj: Applications Are Now Open for 2026 CReDO Workshop for Training Researchers in Oncology
Opinion
Jun 20, 2025, 09:13
Wafik El-Deiry: I Hope Severe Budget Cuts to NIH and NCI Can Be Avoided to Minimize Disruption to Research Progress
Insight
Jun 20, 2025, 09:02
AACR-ACS Award for Research Excellence in Cancer Epidemiology and Prevention: Nominate by June 30
Blog
Jun 20, 2025, 08:33
Join The Webinar On The Global Platform for Access to Childhood Cancer Medicines - SIOP
Blog
Jun 20, 2025, 08:22
Aruni Ghose: I Wanted Access to the NHS InSites Programme for OncoFlow with Maryam Hasanova and I Got It
Blog
Jun 20, 2025, 08:05
Justin Taylor: Roche, AbbVie Announce Trial of Venclexta in Patients with Myelodysplastic Syndromes Falls Short
Blog
Jun 20, 2025, 07:34
Arsen Osipov Co-Authored Phase III PANOVA-3 Study Published on the JCO ASCO - Cancer at Cedars-Sinai
Blog
Jun 20, 2025, 07:18
Arya Roy: Thank You HemOnc Today for Highlighting Our Research
Drugs
Jun 20, 2025, 02:19
Is Tamoxifen Chemotherapy? Understanding Its Role in Breast Cancer Treatment
Blog
Jun 19, 2025, 23:18
Tilly Metz: We Have Finally Started Negotiations On The Reform of Pharmaceutical Policy in Europe